Minnesota follows closely, seeing a 30.6 percent increase in obesity over 10 years. The state’s current obesity rate is 33.3 ...
The book describes Winfrey's long-documented struggle with weight loss and reframes obesity as what Dr. Ania M. Jastreboff ...
AbbVie said on Wednesday it is seeking to expand its presence in the fast-growing market for obesity treatments, leaning on ...
The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...
Oral weight-loss drugs could account for a third or more of the overall GLP-1 market by 2030, a Novo Nordisk executive said ...
Obesity took center stage on the first day of the 2026 J.P. Morgan Healthcare Conference, with industry frontrunners Eli ...
MedPage Today on MSN
GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity
SAN FRANCISCO -- Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and ...
New research calls for routine risk stratification of MASLD in people with obesity to detect and manage liver disease earlier ...
Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect ...
Everyday Health on MSN
Using GLP-1s for Obesity During Menopause: Benefits and Risks
Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...
Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched ...
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback